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Abstract
External quality assurance (EQA) or proficiency testing for point-of-care (POC) testing is in principle similar to EQA for larger hospital laboratories, 
but the participants are different. The participants are usually health care personnel with little or no knowledge of laboratory medicine. The impli-
cation of this is that the EQA provider has to a) convince the participants that participation in EQA schemes are important, b) be able to circulate ma-
terials with reasonable time intervals, c) produce feedback reports that are understandable, and d) offer help and guidance to the participants when 
needed. It is also important that EQA for POC testing e) address the pre-examination, the examination and the post-examination processes, and f) 
that schemes for measurement procedures using interval or ordinal scale are offered. The aim of the present paper is to highlight important issues of 
these essential aspects of EQA for POC testing.
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Introduction
A key issue in external quality assurance (EQA) or 
proficiency testing is to ensure high quality 
schemes and to avoid that participation in such 
schemes does more harm than good. Ideally, any 
EQA program should provide the participants in-
formation of whether their measurement proce-
dure has a bias from a true value (1). An EQA or-
ganisation distributing control material should 
strive to obtain and use native commutable mate-
rials where the target values are set by using a ref-
erence method or a certified reference material (1). 
However, in many cases this is not possible, con-
trol material that is not commutable is used, and 
thus peer group target values must be established. 
Such materials have severe limitations since the 
material may also not be commutable between 
reagent lots within the same method (2,3). Circula-
tion of unsuitable EQA materials could in such cas-
es generate harm by misclassifying participant 
performance.
It is often more difficult to obtain a commutable 
material when the EQA scheme has a high number 
of participants since commutable material is based 
on native patient samples and have a limited sta-
bility. In such cases, smaller (national/regional) 
schemes with fewer participants can be preferred. 
For point-of-care (POC) testing, it is even more dif-
ficult to obtain commutable control materials 
since the matrix generally is whole blood. Often 
different control materials have to be circulated to 
the different POC instruments, and no control ma-
terials are available for some POC instruments, e.g. 
as has been shown for POC international normal-
ized ratio (INR) testing (4). An alternative EQA ap-
proach has been developed in situations where 
commutable control materials are not available (5), 
in which a limited number of selected general 
practitioner (GP) offices perform a split sample 
comparison with a central laboratory method us-
ing native whole blood patient samples. In addi-
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tion, non-commutable EQA materials are circulat-
ed to all participants. In this way, method perfor-
mance is addressed by the split samples system 
and participant performance is addressed by the 
non-commutable material, and the EQA provider 
does not need to circulate native materials to all 
the participants (5).
EQA for POC testing is in many ways similar to EQA 
for larger hospital laboratories. There is, however, 
one important difference that is not always ac-
knowledged; the participants. Whereas the partici-
pants in the EQA schemes for hospital laboratories 
usually are specialists in laboratory medicine or 
medical laboratory scientists, the participants in 
EQA for POC testing are often the end users of the 
tests, i.e. health care personnel with little or no 
knowledge of laboratory medicine. The implica-
tion of this is that the EQA organiser has a) to con-
vince the participants that participation in EQA 
schemes are important, b) be able to circulate ma-
terials with time intervals that are acceptable both 
for the participants and from the organisers point 
of view, c) produce feedback reports that are un-
derstandable by the participants, and d) offer help 
and guidance to the participants when needed. In 
addition, it is important to e) address the pre-ex-
amination, the examination and the post-exami-
nation processes, and f) offer schemes for meas-
urement procedures using interval or ordinal scale. 
The aim of the present paper is to highlight these 
essential aspects of EQA for POC testing.
Convince the participant that EQA is 
important
The common opinion in laboratory medicine is 
that EQA is useful.  This opinion is more or less part 
of our education and we are so used to it that we 
do not question the value of it. However, since we 
with EQA of POC testing are addressing people 
without much knowledge of laboratory medicine 
we have to explain why they should participate in 
this system and what they can gain from it. In fact, 
there is little evidence that participation in EQA is 
useful to improve the quality of the results and no 
evidence concerning the benefit for the patients. 
The reason for this is partly that it is difficult to iso-
late the “EQA factor” from other factors that can 
contribute to the improvement of the quality of 
the examination processes. In a recent paper by 
Bukve et al., looking at the development of the an-
alytical quality for POC analyses during a period of 
9 years, it could be shown that the number of 
times the participants participated in an EQA pro-
gram for POC glucose, haemoglobin and C-reac-
tive protein (CRP) testing, was an independent fac-
tor associated with improved analytical quality of 
these analytes (6). Other independent factors as-
sociated with improved analytical quality were 
type of instrument, performing internal quality 
control weekly, performing 10 or more patient 
tests weekly, and having laboratory-qualified per-
sonnel performing the tests. Another important 
factor, which was not investigated in the study by 
Bukve et al. was that the POC testing laboratories 
participated in a quality improvement follow-up 
system in which they always had somebody to 
contact if they had problems with the tests. To the 
authors knowledge, this study  is the first evidence 
that EQA for POC testing is useful (6).
Frequency of EQA schemes
The optimal frequency of EQA schemes is often 
debated and the evidence for an optimal frequen-
cy is difficult to find. Looking through the cata-
logues of different EQA providers, it is easy to see 
that the frequency of EQA surveys varies, and the 
scientific reason for this is not given. In these au-
thors opinion, a high quality scheme with com-
mutable material and reference target values and 
thoroughly elaborated and understandable feed-
back reports are much more important than 
schemes with a high number of surveys. The theo-
retical reason for this opinion is that EQA should 
not be a substitute for internal quality control, but 
should concentrate on finding systematic devia-
tions of measurement procedures preferably from 
a true target value.  In cases where deviations are 
found, the users of the tests should be followed up 
by direct contact. This is of course even more im-
portant with POC testing since the users are clini-
cians, nurses and health care personnel with little 
or no education in laboratory medicine. One im-
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portant factor that promotes a high frequency of 
schemes is money. It is common that EQA provid-
ers are paid by each survey they circulate, mean-
ing that more money is earned if surveys are circu-
lated more frequently. An alternative approach 
could be that the EQA providers are paid for the 
expertise they provide so that professional rea-
sons could determine the optimal frequency of 
surveys and the content of the feedback reports. A 
working group in the European Organisation for 
External Quality Assurance Providers in Laborato-
ry Medicine (EQALM) is currently investigating the 
optimal frequency of EQA schemes, and the goal 
is to provide guidance on evidence based models 
for EQA design (7).
Feedback reports
Feedback reports from EQA schemes are often 
comprehensive and complicated, and can be diffi-
cult to understand. However, such comprehensive 
reports can be very useful for skilled personnel in 
large laboratories, e.g. it can help them look at 
time trends, concentration effects, calibration, etc. 
For the users of POC tests on the other hand, only 
two basic aspects are important: 1) is my result 
correct and 2) if not, what can I do to improve it? 
The feedback reports must therefore be simple 
and educational. It is important to explain for the 
participants if a deviant result is caused by the in-
strument they are using, by the reagent lot they 
are using or by their own performance. Therefore, 
the participants should report which instrument 
and reagent lot they have used in addition to the 
control results. It is then easier to identify the rea-
son for a deviant EQA result and to describe this in 
the feedback report. Reagent lot information is of-
ten not given in EQA, probably because it is as-
sumed that lot variation is detected by internal 
quality control. However, this can be more difficult 
to achieve for POC testing. In a recent paper deal-
ing with POC tests for urine albumin:creatinine ra-
tio (ACR) and INR it was shown that there indeed 
could be large lot variations for these analytes, de-
tected by the EQA control material (8). Concerning 
INR, a non-commutable material was used and it 
could be shown that the material was even not 
commutable within the method studied, i.e. the 
material was not commutable between reagent 
lots. The lot variation found did not reflect results 
obtained from native patient samples. Thus, if this 
had not been discovered, the feedback report 
could easily have resulted in “more harm than 
good”. In contrast, for ACR where a commutable 
material was used, the lot variation was also found 
using patient samples and this variation could 
therefore have clinical implications. Again, infor-
mation about the reagent lots was of the utmost 
importance for the understanding of the EQA re-
sults and the feedback reports.
It could be valuable if the EQA provider asks for 
different characteristics of the participants in order 
to understand which factors are associated with 
good quality. Such factors could for example be 
the frequency of running internal quality control, 
the number of tests performed per week, the pro-
fession of the test operator, and the number of 
employees (6).
Help and guidance to the participants
In general, EQA participants should have the op-
portunity to seek help and guidance when need-
ed. For participants in primary health care it is 
even more important to have someone they can 
address when they have problems to interpret the 
feedback reports, and most importantly to decide 
what actions should follow a deviant result. The 
EQA provider should have the responsibility to es-
tablish such follow-up system. In a hospital, how-
ever, the central laboratory could have responsibil-
ity for the POC analyses at the wards and thus also 
to educate and guide the POC users in EQA issues. 
Such supervision system might be easier to organ-
ize within a hospital environment than in primary 
health care. The POC manufacturers are also re-
sponsible to have a system to educate, guide and 
follow-up the POC users.
In 1992, the Norwegian Quality Improvement of 
Primary Care Laboratories (Noklus) (9) was estab-
lished and one pre-requisite for starting this or-
ganisation was that there should be a system 
where the users could get sound advice. There-
fore, in addition to establish an EQA organization, 
a system with more than 40 laboratory advisers 
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sited all over Norway was established. Each labora-
tory advisor has the responsibility for about 50-
100 units like e.g. GP offices, nursing homes, emer-
gency healthcare centres, occupational healthcare 
centres, and oil platforms. 99.8% of all GP offices 
and 96% of all nursing homes in Norway partici-
pates in Noklus voluntary. The main tasks for the 
laboratory advisors are to visit the participants, or-
ganize courses, offer advice concerning which in-
strument to buy, and follow up results from EQA 
schemes. In principle, these advisors contact all 
participants in Norway with poor performance. 
Since the choice of instrument is very important 
for the quality of patient results, the Scandinavian 
Evaluation of laboratory equipment for primary 
health care (SKUP) (10,11) was established.
EQA of the total examination process
Whereas most attention from EQA providers has 
been focused on the analytical examination, more 
and more attention is drawn to the pre- and post-
examination processes. Many EQA providers are 
now circulating pre- and post-examination 
schemes alone or embarked in the analytical 
schemes. Especially the post-examination sche-
mes are important for POC testing since there is a 
direct communication with the end-users of the 
tests. It is then possible to examine how the test 
results influence their clinical decisions and indi-
rectly also ascertain what performance they be-
lieve they have (12). By combining the feedback of 
analytical quality with feedback on how the clini-
cians use the test, it is possible to generate a 
strong educational material concerning the value 
of laboratory tests and how important it is that 
tests conform to given performance specifications. 
Noklus has run a series of case history based EQA 
surveys over years (13) showing that clinicians have 
widely different knowledge of the analytical quali-
ty of the tests they are using.
Measurement procedures using the 
nominal or ordinal scale
A nominal scale deals with classification of a quan-
tity irrespective of magnitude, e.g. type of virus, 
bacteria, or mutations whereas an ordinal scale 
deals with all types of grading, e.g. urine strips for 
glucose or  human chorionic gonadotrophin (hCG) 
(14,15). Generally, measurements performed on an 
ordinal scale are measurements that can also be 
performed on a ratio or interval scale. The quanti-
ties are often measured on an ordinal scale be-
cause a more rapid test result can be obtained and 
because people without much laboratory experi-
ence can perform such tests. Thus, these tests are 
commonly used as POC tests in for example GP of-
fices, nursing homes and rural areas (16,17).
EQA of the ordinal scale can be used for different 
types of POC tests, such as for example HIV, malar-
ia and tuberculosis (18). EQA of such tests raise 
specific challenges because the users have more 
difficulties to understand the value of such EQA 
(19). In an EQA for POC on the ordinal scale, sam-
ples are typically circulated with concentrations 
that are expected, with a very high probability to 
give “positive” or “negative” results. In addition, 
samples with an intermediate concentration are 
circulated. The participants will get an evaluation 
only with respect to the “positive” or “negative” 
samples since they are supposed to classify these 
samples correct (18). Samples with intermediate 
concentrations will give results that are expected 
to be both “positive” and “negative.” This informa-
tion is useful to assess and to monitor the perfor-
mance of the POC tests, but not to assess the user 
performance. Therefore, it is important to also cir-
culate samples with intermediate concentrations, 
but this must be thoroughly explained to the us-
ers so that they can see a benefit from it.
Conclusion
EQA for POC testing is in principle similar to EQA 
for larger hospital laboratories, but there are some 
important differences. The participants are often 
the end-users of the tests (e.g. clinicians and nurs-
es), they have usually little or no knowledge of lab-
oratory medicine and the number of participants 
is often high. This gives the EQA providers some 
extra challenges; they must convince the partici-
pants that participation in EQA schemes are im-
portant, be able to circulate materials with reason-
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able time intervals, produce feedback reports that 
are understandable by the participants, and offer 
help and guidance to the participants when need-
ed. It is also important that EQA for POC testing 
address the total examination process, and that 
schemes for measurement procedures using inter-
val or ordinal scale are offered.
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